On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.
- Morgan Stanley laid out its bullish case for why investors should buy ASML Holding NV (ASML) shares, saying in the most optimistic scenario the stock has a 70% rally ahead as chipmakers ramp up spending to meet soaring demand for artificial intelligence. The Dutch semiconductor equipment maker is one of the bank’s top stock picks. Morgan Stanley analysts said they’re even more positive after Taiwan Semiconductor Manufacturing Co., ASML’s biggest client, showed the AI spending boom isn’t slowing down. ASML shares are up 25% so far in 2026, marking a roaring start to the year.
- ImmunityBio (IBRX) shares advanced for a 11th straight session — a record streak after the company gave efficacy results from a clinical cancer trial. The stock is also on pace for its biggest weekly gain since October 2023 and its best month since December 2019.
- Constellation Energy (CEG) as well as other independent power producers saw shares decline after the Trump administration and several states laid out a plan intended to compel technology companies to effectively fund the construction of new power plants as a way to tame surging consumer utility bills while aiding the development of data centers. Shares of the largest independent power producers slid. Vistra Corp. declined as much at 9.5%, Talen Energy Corp. slipped as much as 11% and Constellation Energy Corp. dropped as much as 10%.
See omnystudio.com/listener for privacy information.
